Necrosis Is Not the Main Part of Immune-Related Pathologic Response to Neoadjuvant Immunotherapy in Squamous Cell Lung Cancer
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference5 articles.
1. IASLC multidisciplinary recommendations for pathologic assessment of lung cancer resection specimens following neoadjuvant therapy;Travis;J Thorac Oncol,2020
2. Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC);Cottrell;Ann Oncol,2018
3. Pan-tumor pathologic scoring of response to PD-(L)1 blockade;Stein;Clin Cancer Res,2020
4. Neoadjuvant PD-1 inhibitor (sintilimab) in non-small cell lung cancer;Gao;J Thorac Oncol,2020
5. Fibrous stroma is associated with poorer prognosis in lung squamous cell carcinoma patients;Takahashi;J Thorac Oncol,2011
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional, propensity score-matching cohort analysis;Therapeutic Advances in Medical Oncology;2024-01
2. Progress on neoadjuvant immunotherapy in resectable non-small cell lung cancer and potential biomarkers;Frontiers in Oncology;2023-01-24
3. Case report: Brain metastasis necrosis with immune checkpoint inhibitors plus chemotherapy for advanced non-small cell lung cancer;Frontiers in Immunology;2022-12-01
4. Immune-related histologic phenotype in pretreatment tumour biopsy predicts the efficacy of neoadjuvant anti-PD-1 treatment in squamous lung cancer;BMC Medicine;2022-10-24
5. Pathologic Assessment of Lung Squamous Cell Carcinoma After Neoadjuvant Immunotherapy;Journal of Thoracic Oncology;2021-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3